Literature DB >> 33029741

Regulation of GSK3β by Ser389 Phosphorylation During Neural Development.

Belen Calvo1, Tina M Thornton2, Mercedes Rincon2,3, Pedro Tranque1, Miriam Fernandez4.   

Abstract

GSK3β is a constitutively active kinase that promotes cell death, which requires strict regulatory mechanisms. Although Akt-mediated phosphorylation at Ser9 is the default mechanism to inactivate GSK3β, phosphorylation of GSK3β at Ser389 by p38 MAPK has emerged as an alternative inhibitory pathway that provides cell protection and repair in response to DNA damage. Phosphorylation of Ser389 GSK3β has been detected in adult brain, where it has been related to neuronal survival and behavior. However, the use of this pathway to regulate GSK3β in the neonatal developing brain is unknown. In this study, we show that phosphorylation of GSK3β at Ser389 in the brain is developmentally regulated, with the highest levels corresponding to the first 2 weeks of age. Moreover, we found that the phosphorylation of GSK3β at Ser389 is the preferential mechanism for inactivating brain GSK3β in 2-week-old mice. Importantly, we show that phospho-Ser389 GSK3β expression is predominant in neuronal cell cultures from neonatal brain relative to other cell populations. However, phospho-Ser389 GSK3β is triggered by DNA double-strand breaks in all developing neural cell types examined. Thus, the phosphorylation of GSK3β on Ser389 could be a central regulatory mechanism to restrain GSK3β during neurogenesis early in life.

Entities:  

Keywords:  Astrocytes; DNA double-strand breaks (DSBs); Microglia; Neural precursor cells (NPCs); Neurons; p38 MAPK

Year:  2020        PMID: 33029741     DOI: 10.1007/s12035-020-02147-2

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  34 in total

Review 1.  GSK3 signalling in neural development.

Authors:  Eun-Mi Hur; Feng-Quan Zhou
Journal:  Nat Rev Neurosci       Date:  2010-08       Impact factor: 34.870

2.  Cell biology. GSK-3beta and microtubule assembly in axons.

Authors:  Feng-Quan Zhou; William D Snider
Journal:  Science       Date:  2005-04-08       Impact factor: 47.728

3.  Developmental expression and localization of glycogen synthase kinase-3beta in rat brain.

Authors:  K Leroy; J P Brion
Journal:  J Chem Neuroanat       Date:  1999-06       Impact factor: 3.052

Review 4.  Stressed and Inflamed, Can GSK3 Be Blamed?

Authors:  Richard S Jope; Yuyan Cheng; Jeffrey A Lowell; Ryan J Worthen; Yoel H Sitbon; Eleonore Beurel
Journal:  Trends Biochem Sci       Date:  2016-11-19       Impact factor: 13.807

5.  Failure to Inactivate Nuclear GSK3β by Ser389-Phosphorylation Leads to Focal Neuronal Death and Prolonged Fear Response.

Authors:  Tina M Thornton; Brendan Hare; Sandra Colié; William W Pendlebury; Angel R Nebreda; William Falls; Diane M Jaworski; Mercedes Rincon
Journal:  Neuropsychopharmacology       Date:  2017-08-17       Impact factor: 7.853

Review 6.  Glycogen synthase kinase 3 beta (GSK3β) at the tip of neuronal development and regeneration.

Authors:  Oscar Seira; José Antonio Del Río
Journal:  Mol Neurobiol       Date:  2013-10-25       Impact factor: 5.590

Review 7.  Innate and adaptive immune responses regulated by glycogen synthase kinase-3 (GSK3).

Authors:  Eléonore Beurel; Suzanne M Michalek; Richard S Jope
Journal:  Trends Immunol       Date:  2009-10-14       Impact factor: 16.687

8.  Localization and developmental changes of tau protein kinase I/glycogen synthase kinase-3 beta in rat brain.

Authors:  M Takahashi; K Tomizawa; R Kato; K Sato; T Uchida; S C Fujita; K Imahori
Journal:  J Neurochem       Date:  1994-07       Impact factor: 5.372

9.  GSK-3 is a master regulator of neural progenitor homeostasis.

Authors:  Woo-Yang Kim; Xinshuo Wang; Yaohong Wu; Bradley W Doble; Satish Patel; James R Woodgett; William D Snider
Journal:  Nat Neurosci       Date:  2009-10-04       Impact factor: 24.884

Review 10.  The GSK3 hypothesis of Alzheimer's disease.

Authors:  Claudie Hooper; Richard Killick; Simon Lovestone
Journal:  J Neurochem       Date:  2007-12-18       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.